0001965301-23-000119.txt : 20230908
0001965301-23-000119.hdr.sgml : 20230908
20230908164250
ACCESSION NUMBER: 0001965301-23-000119
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230908
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Roivant Sciences Ltd.
CENTRAL INDEX KEY: 0001635088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981173944
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-40782
FILM NUMBER: 231245807
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON HM11
STATE: D0
ZIP: HM11
BUSINESS PHONE: 441-295-5950
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kumar Rakhi
CENTRAL INDEX KEY: 0001856296
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O NEUROPACE INC
STREET 2: 455 N BERNARDO AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
144
1
primary_doc.xml
144
0001856296
XXXXXXXX
LIVE
0001635088
Roivant Sciences Ltd.
001-40782
CLARENDON HOUSE, 2 CHURCH STREET
HAMILTON HM11
D0
HM11
441-295-5950
Kumar Rakhi
Officer
common
ROCKEFELLER FINANCIAL, LLC
45 ROCKEFELLER PLAZA - FLOOR 5
New York
NY
10111
99350
1210024.02
771742197
09/08/2023
Nasdaq
Common
09/08/2023
Options Exercise - Grant Date - 05/22/2017
Roivant Sciences Ltd
N
99350
09/08/2023
wire
N
Rakhi Kumar
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
43893
06/09/2023
43893
435726.62
Rakhi Kumar
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
Common
06/22/2023
1357
13583.57
Rakhi Kumar
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
common
07/14/2023
535
6420.00
Rakhi Kumar
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
common
07/18/2023
100
1200.00
Rakhi Kumar
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
common
07/24/2023
1393
15309.07
Rakhi Kumar
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
common
08/01/2023
336
4032.00
Rakhi Kumar
c/o Roivant Sciences Ltd
7th Floor, 50 Broadway
London
X0
SW1H 0DB
common
08/03/2023
3681
44172.00
Rakhi Kumar
c/o Roivant Sciences Ltd
7th Floor, 50 Broadway
London
X0
SW1H 0DB
common
08/22/2023
1378
14923.74
Rakhi Kumar
c/o Roivant Sciences Ltd. 7th Floor
50 Broadway
London
X0
SW1H 0DB
common
09/05/2023
1724
20690.00
The shares reported on this form 144 will be sold pursuant to Rule 10b5-1 trading plan adopted by the reporting person on 2/25/2023.
09/08/2023
02/25/2023
Jason Coleman as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Rakhi Kumar